SNN - Smith & Nephew plc

NYSE - Nasdaq Real Time Price. Currency in USD

Smith & Nephew plc

15 Adam Street
London WC2N 6LA
United Kingdom
44 20 7401 7646
http://www.smith-nephew.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees15,000

Key Executives

NameTitlePayExercisedAge
Mr. Olivier BohuonCEO & Director3.1MN/A58
Mr. Graham Timothy BakerCFO & Exec. DirectorN/AN/A49
Mr. Matthew R. StoberPres of Global OperationsN/AN/A49
Mr. Arjun RajaratnamChief Compliance OfficerN/AN/AN/A
Ms. Catheryn O'RourkeChief Legal OfficerN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints; and arthroscopic enabling technologies for healthcare providers, such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue. It also provides trauma and extremities products consisting of internal and external devices used in the stabilization of severe fractures and deformity correction procedures; robotics-assisted surgery products and services; knee implant products for specialized knee replacement procedures; and hip implant products for reconstruction of the hip joint, as well as various products and technologies to assist in surgical treatment of the ear, nose, and throat. In addition, the company offers advanced wound care products for the treatment of acute and chronic wounds, including leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound devices, including traditional and single-use negative pressure wound therapy and hydrosurgery systems; and biologics and other bioactive technology products for debridement and dermal repair/regeneration. It primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.

Corporate Governance

Smith & Nephew plc’s ISS Governance QualityScore as of December 1, 2017 is 3. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 1; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.